PYGB: Key Enzyme in Glycogen Breakdown (G5834)

Target Name: PYGB

NCBI ID: G5834

PYGB

PYGB: Key Enzyme in Glycogen Breakdown

Glycogen phosphorylase B (PYGB) is a protein that is involved in the breakdown of glycogen, which is a form of stored glucose that is found in the liver. PYGB is a key enzyme in the glycogen breakdown pathway, and it is involved in the first step of the process, which involves the breakdown of the 尾-glucan molecule that makes up the glycogen.

PYGB is a member of the glycogen branch of the glycogen breakdown pathway, which is a complex network of enzymes that is involved in the breakdown of glycogen. The glycogen breakdown pathway is a critical pathway for the body to produce glucose, which is the primary source of energy for the body.

PYGB is a key enzyme in the first step of the glycogen breakdown pathway, which involves the breakdown of the 尾-glucan molecule. 尾-glucan is a complex carbohydrate that is found in the cell walls of many plants, and it is made up of many glucose molecules that are bonded together in a specific arrangement. PYGB is the enzyme that is responsible for breaking down this complex carbohydrate into its individual glucose molecules.

The breakdown of 尾-glucan by PYGB is a critical step in the glycogen breakdown pathway, as it allows the body to produce the simple sugars that can be used as the body's primary source of energy. Once the 尾-glucan has been broken down into its individual glucose molecules, it is transported into the liver, where it is stored for later use.

In addition to its role in the glycogen breakdown pathway, PYGB is also involved in the regulation of many other cellular processes in the body. For example, PYGB has been shown to be involved in the regulation of cell growth, and it has been shown to play a role in the development and progression of many diseases, including cancer.

PYGB is also a potential drug target, and its involvement in the glycogen breakdown pathway makes it an attractive target for researchers who are interested in the use of PYGB as a therapeutic agent. One way to target PYGB is through the use of small molecules that can inhibit its activity, such as drugs that bind to specific regions of the PYGB protein. These drugs could be used to treat a variety of diseases, including cancer, diabetes, and obesity.

Another approach to targeting PYGB is through the use of antibodies that are designed to specifically recognize and target the PYGB protein. These antibodies could be used to treat diseases in which PYGB is hyperactive or dysfunctional, such as cancer, diabetes, and obesity.

Overall, PYGB is a protein that is involved in the breakdown of glycogen, which is a critical source of energy for the body. PYGB is also involved in the regulation of many other cellular processes in the body, and it is a potential drug target for the treatment of a variety of diseases. Further research is needed to fully understand the role of PYGB in the body and its potential as a therapeutic agent.

Protein Name: Glycogen Phosphorylase B

Functions: Glycogen phosphorylase that regulates glycogen mobilization (PubMed:27402852). Phosphorylase is an important allosteric enzyme in carbohydrate metabolism (PubMed:3346228). Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates (PubMed:3346228). However, all known phosphorylases share catalytic and structural properties (PubMed:3346228)

The "PYGB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PYGB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets